55ESPE 7-5-RFC commonly testes in requirements, → iron overload pituitary the in less & gland beta major, thalassemia dueto chronic disease and transfusion Delayed puberty and hypogonadism are common children in with Problems of iron overload C i F proliferate then seminiferous outgrowthtubule adolescence. in occurs. Foetal/postnatal no spermatogenesis is until puberty. option not available is This for preserve fertility options toprior cryopreservation of ejaculated or surgically retrieved sperm can menorlateIn adult peri n bone marrow regimes have devastating effects on the conditioning regimens that compromise fertility. Bone Marrow Transplantation ( BMTX) Background cell pool pool cell time frame, for conditions such as thalassemia major, or Less commonly it is possible to plan the setting or in of deficiencyimmune syndromes. leukaemia, after failed chemotherapy or relapse of procedure, modality of cancerprimary careas a for risk high The common BMTx situation of is Fertilitypreservation options months from first endocrine consultation. time span, prior to bonemarrow transplant planned for 6 Aims: beta major thalassemia We theuseof describe Patient and methods d E y R

H T o 1 I to inducepuberty andspermatogenesis, over a short , L 2 Sertoli , I margaret zacharin Gonads & DSD M  T a Y r lack of functional gametes functional of lack

g P a cells maturecells germ childhood, during cells r dysplasias R e t E gonocyte

Z S a c E h R a r V i hCG n - A . 1 and post pubertal adolescent , males , T

differentiation to

1 I D and FSH ina 13year boy old with O e P p N prepubertal a t e

o gonadotoxic P d I f as an urgentas an or semi i N

R a E t n

I r BMTx A O i d c o s  N involves useofpre R , c

K r spermatogonial

i h n sterility A T o o boys becausethere within a larger O D o l spermatogonia o

B T g O treatments. e y O , c L

k M Many E

N P u S u leukaemia r E a d C

t o M - E - c N urgent h N a

A stem t C - i T o h R - n

i 9 l B DOI: 10.3252/pso.eu.55ESPE.2016 R d a l r O

O e U n n Y W ’ s i : v

R e I

e r N T s s i e R t D y a A

r C U c N h h C

i I l S n d Rx: Human chorionic gonadotropin Human chorionic Rx: ( Parental consent obtained for pubertal : induction BMTx ageBone 13 Remained Followed for 8months FH (NR<370) optimalSub chelation for years (Ferritin 5450mcg/l Regular transfusions blood 3 weekly from age 2.5 agedMale 12.2 years at first consultation endocrine Four months after semen collectionhe underwent Cryopreservation of 11 straws 0.5- after start ofFSH Semen collection performed 9 months Evidence for fertility 50 135ng/L(NR B Inhibin Testosterone12- (NR 17.6 testes20ml bilaterally Adult height 167.5cm, Outcome over 9months : • stimulating hormone (FSH) 150 IU x3/week added, • Pubertal progress mildly accelerated  s/cper week twice I Busulphan marrowbone transplantation, preceded by for ofspermatogenesis induction s N P adolescent males, prior toadolescentprior males, be consideredshould This optionin future, for other . Fertility preservation case this in is assured bone marrowtransplant. fertility,in ayoung and spermatogenesis puberty inducing adequate for future This reportprovides first the evidence offeasibility of Conclusions r t e to 1000units x2 /week after 3months i increased after 3 months to 300units weekly.thrice When serum testosteroneserum When Follicle 11.9nmol/l, L t n G u 1.8million/ml. on 3samples ’ A s t

e P presented Poster M N virilization planned forplanned 6months ,

U R e T o d A B y i c prepubertal a T a E conditioning. l at:

l I C

R I O n h T s i N l t d Y , i t r

u

e A t n prepubertal e ’ N s

H D with 2ml testes 2ml with bilaterally o s -

350) p S 24) gonadotoxic i P t a E l , nmol

R A adolescent male, prior toadolescentmale, prior u M s t r /L A a l T hCG i Thal a O treatments ,

2 D G ) 500units ) 500units e major E p a N r t E m S e n I S t yrs

o

f